Cystadane Powder, For Solution
Product Images NDC 52276-400

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cystadane (NDC 52276-400). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Recordati Rare Diseases, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Betaine Anhydrous Structural Formula (Cystadane 01)

Chemical structure diagram showing the molecular structure of betaine with labeled carbon and nitrogen atoms, including three methyl groups attached to the nitrogen, an ethylene group, and a carboxylate functional group.*

FDA Label Image

Recordati Rare Diseases Logo (Cystadane 02)

FDA Label Image

Principal Display Panel (180 Gram Bottle Label)

Label for Cystadane powder for oral solution, containing 1 gram of betaine anhydrous powder per scoop. The package contains 180 grams. Manufactured by Recordati Rare Diseases, with distribution in the USA by Recordati Rare Diseases Inc. The label includes preparation instructions and storage guidelines. NDC 52276-400-01 is visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.